Immune history confers antibody- and T cell-dependent cross-protection against highly pathogenic avian influenza H5N1 viruses. [PDF]
Brigleb PH +17 more
europepmc +1 more source
Cross-sectional study on protective antibodies against influenza A virus subtypes and cross-protection against influenza A(H3N2) subclade K, Portugal, August 2025. [PDF]
Guiomar R +8 more
europepmc +1 more source
Interim 2025/26 influenza vaccine effectiveness estimates with immuno-epidemiological considerations for A(H3N2) subclade K protection, Canada, January 2026. [PDF]
Separovic L +18 more
europepmc +1 more source
Comparative analysis of cellular immune responses to four seasonal inactivated influenza vaccines in younger and older adults. [PDF]
Silva-Moraes V, Reis LR, Ross TM.
europepmc +1 more source
Clinical Serum-Anchored Computational Design Pipeline for a Broad-Spectrum Influenza Multi-Epitope mRNA Vaccine. [PDF]
Yuan L +14 more
europepmc +1 more source
Intranasal Mosaic H1N1 Live Attenuated Influenza Vaccine Elicits Broad Cross-Reactive Immunity and Protection Against Group 1 and 2 Influenza A Viruses. [PDF]
Ma X +16 more
europepmc +1 more source
Confined Synthesis of Axial Chlorine Coordinated Single-Atom Nanozyme Within Liposomes for Sensitive Immunoassay. [PDF]
Chu C +11 more
europepmc +1 more source
Assessment of immunogenicity and protection induced by COBRA HA vaccines formulated with Infectimune in young and elderly ferrets. [PDF]
Zhang X +4 more
europepmc +1 more source

